2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague

2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague

Motley Fool

Published

Two drug developers stand out as plain-as-day bargains in the new year, while another top-performing biotech stock looks poised to disappoint.

Full Article